Test: Infection, Tumor imaging, and Therapy Review Test (1/3) (employee training


Infection, Tumor imaging, and Therapy Review Test (1/3)Versión en línea T/F questions por Joshua Liberty 1 I-125 has Tp of 35.5 days; it decays by EC; it has 27.4 and 31 KeV x-rays and a 60 KeV gamma. a True b False 2 Y-90 labeled glass microspheres is being used; the formula for dose calculation is; Activ required in GBq=(liver mass in Kg/ Desired dose in Gys)/50. a True b False 3 Tilmanocept is DTPA-mannosyl-dextran, a macromolecule with an average diameter of between 100 and 220 nm a True b False 4 Tilmanocept may be administered to a patient as a single injection or as multiple injections. a True b False 5 Smaller particles are generally recommended in lymphoscintigraphy as more frequent visualization of lymphatic channels is activated. a True b False 6 With lymphoscintigraphy for melanoma, imaging begins immediately after injection and is repeated at 5 minute intervals for 45 to 60 minutes. a True b False 7 Usual dose for Ga-67 Citrate is 5-10 mCi. a True b False 8 With Ga-67 Citrate, the reason for delayed views is concentration in tissue is stable while blood clearance improves over time. a True b False 9 With In-111 Oxine labeled WBCs, early lung activity occurs, then clears out. a True b False 10 With In-111 Oxine labeled WBCs, uptake in liver and spleen is abnormal. a True b False 11 Leukocyte agents are nonspecific and also localize in areas of inflammation, without infection. a True b False 12 Sestamibi Breast imaging should be delayed 2 weeks following FNA and 4-6 weeks post core biopsy. a True b False 13 The main disadvantage with Tc99m HMPAO WBC imaging is the tag to WBCs begins to breakdown leading to renal and GI excretion-this complicates GI infection localization. a True b False 14 Use of Y-90 labeled Glass Microspheres is contradicted in patients whose Tc99m MAA hepatic arterial perfusion scintigraphy shows any deposition to the GI tract that may not be corrected by angiographic techniques. a True b False 15 A tech cannot find a vein on a In-111 WBC patient; he can try using a 25g needle with no effect on scan. a True b False 16 Both benign and malignant conditions can result in lung nodules. a True b False 17 Patient should have no strenuous activity for 24 hours before PET/FDG scan. a True b False 18 Ideal patient blood glucose is 200mg/dl before FDG scan? a True b False 19 The most common adult FDG dose is 10 mCi. a True b False 20 ROCM enhancement occurs because it lets more photons through. a True b False 21 Total body PET FDG scanning is ideal for malignant melanoma and sarcoma patients. a True b False 22 In PET/CT, acquiring images with patients arms to the side would increase beam hardening and truncate CT data. a True b False 23 Gliomas are the most common brain tumors. a True b False 24 PET FDG is better than bone scans for prostate cancer mets. a True b False 25 Obese patients have lower SUVs for both normal and malignant tissue. a True b False 26 Due to partial volume effects , SUV of lesions smaller than the spatial resolution of the scanner will be overestimated. a True b False 27 I-125 seeds are indicated for permanent interstitial treatment of selected localized tumors such as ;head and neck, lung, pancreas, and early stage prostate. a True b False 28 Fluciclovine F-18 uptake is not specific for prostate cancer and may occur with other types of cancer and benign prostatic hypertrophy in primary prostate cancer. a True b False 29 Before initiating Lu-177 Dotatate; Discontinue long-acting somatostatin analogs (E.g. long-acting octreotide) for at least 4 weeks prior to initiating therapy. Administer short-acting octreotide as needed; discontinue at least 24 hours prior to initiating therapy. a True b False 30 Secondary brain tumors are more prevalent in the pediatric population while adults are more prone to experience primary brain tumors. a True b False

1

I-125 has Tp of 35.5 days; it decays by EC; it has 27.4 and 31 KeV x-rays and a 60 KeV gamma.

a

True

b

False

2

Y-90 labeled glass microspheres is being used; the formula for dose calculation is; Activ required in GBq=(liver mass in Kg/ Desired dose in Gys)/50.

a

True

b

False

3

Tilmanocept is DTPA-mannosyl-dextran, a macromolecule with an average diameter of between 100 and 220 nm

a

True

b

False

4

Tilmanocept may be administered to a patient as a single injection or as multiple injections.

a

True

b

False

5

Smaller particles are generally recommended in lymphoscintigraphy as more frequent visualization of lymphatic channels is activated.

a

True

b

False

6

With lymphoscintigraphy for melanoma, imaging begins immediately after injection and is repeated at 5 minute intervals for 45 to 60 minutes.

a

True

b

False

7

Usual dose for Ga-67 Citrate is 5-10 mCi.

a

True

b

False

8

With Ga-67 Citrate, the reason for delayed views is concentration in tissue is stable while blood clearance improves over time.

a

True

b

False

9

With In-111 Oxine labeled WBCs, early lung activity occurs, then clears out.

a

True

b

False

10

With In-111 Oxine labeled WBCs, uptake in liver and spleen is abnormal.

a

True

b

False

11

Leukocyte agents are nonspecific and also localize in areas of inflammation, without infection.

a

True

b

False

12

Sestamibi Breast imaging should be delayed 2 weeks following FNA and 4-6 weeks post core biopsy.

a

True

b

False

13

The main disadvantage with Tc99m HMPAO WBC imaging is the tag to WBCs begins to breakdown leading to renal and GI excretion-this complicates GI infection localization.

a

True

b

False

14

Use of Y-90 labeled Glass Microspheres is contradicted in patients whose Tc99m MAA hepatic arterial perfusion scintigraphy shows any deposition to the GI tract that may not be corrected by angiographic techniques.

a

True

b

False

15

A tech cannot find a vein on a In-111 WBC patient; he can try using a 25g needle with no effect on scan.

a

True

b

False

16

Both benign and malignant conditions can result in lung nodules.

a

True

b

False

17

Patient should have no strenuous activity for 24 hours before PET/FDG scan.

a

True

b

False

18

Ideal patient blood glucose is 200mg/dl before FDG scan?

a

True

b

False

19

The most common adult FDG dose is 10 mCi.

a

True

b

False

20

ROCM enhancement occurs because it lets more photons through.

a

True

b

False

21

Total body PET FDG scanning is ideal for malignant melanoma and sarcoma patients.

a

True

b

False

22

In PET/CT, acquiring images with patients arms to the side would increase beam hardening and truncate CT data.

a

True

b

False

23

Gliomas are the most common brain tumors.

a

True

b

False

24

PET FDG is better than bone scans for prostate cancer mets.

a

True

b

False

25

Obese patients have lower SUVs for both normal and malignant tissue.

a

True

b

False

26

Due to partial volume effects , SUV of lesions smaller than the spatial resolution of the scanner will be overestimated.

a

True

b

False

27

I-125 seeds are indicated for permanent interstitial treatment of selected localized tumors such as ;head and neck, lung, pancreas, and early stage prostate.

a

True

b

False

28

Fluciclovine F-18 uptake is not specific for prostate cancer and may occur with other types of cancer and benign prostatic hypertrophy in primary prostate cancer.

a

True

b

False

29

Before initiating Lu-177 Dotatate; Discontinue long-acting somatostatin analogs (E.g. long-acting octreotide) for at least 4 weeks prior to initiating therapy. Administer short-acting octreotide as needed; discontinue at least 24 hours prior to initiating therapy.

a

True

b

False

30

Secondary brain tumors are more prevalent in the pediatric population while adults are more prone to experience primary brain tumors.

a

True

b

False

Infection, Tumor imaging, and Therapy Review Test (1/3)

Test

Descarga la versión para jugar en papel

Creada por

Top 10 resultados

Top juegos

Test

cuanto sabes de Futbol

Test

Verbos irregulares en Inglés

Test

Cultura general española

Test

Brawl stars preguntas

Test

Tipos de sintagmas (II)